Dr. Robert Hendel
Professor of Medicine and Radiology, Sidney W. & Marilyn S. Lassen Chair in Cardiovascular Medicine
Areas of Expertise
Biography
Robert C. Hendel, MD, FACC, FAHA, MASNC is the Sidney W and Marilyn S. Lassen Chair in Cardiovascular Medicine and a Professor of Medicine and Radiology at the Tulane University School of Medicine. He also serves as the Chief of the Section of Cardiology and Director of the Tulane University Heart and Vascular Institute.
Dr. Hendel has served at the national level as the President of the American Society of Nuclear Cardiology and as President of the Cardiovascular Council of the Society of Nuclear Medicine (SNM) and received the Hermann Blumgardt Award from the SNM for outstanding service in nuclear cardiology. He is presently serving a second three-year on the Board of Trustees was a member of the appropriate use criteria task force at the ACC and has pioneered the implementation and evaluation of appropriate use criteria. He has also chaired the ACC/AHA Task Force on Clinical Data Standards. He is a Fellow of the American College of Cardiology (FACC), the American Heart Association (FAHA), and a Master of the American Society of Nuclear Cardiology (MASNC).
Dr. Hendel has delivered invited lectureships at the American Heart Association, American College of Cardiology, Society of Nuclear Medicine, and the American Society of Nuclear Cardiology scientific sessions, as well as at national conferences in more than 25 countries. He has also authored more than 200 papers and book chapters and has published three of the leading textbooks in nuclear cardiology. He serves on the editorial board for multiple journals, including the Journal of Nuclear Cardiology and is a section editor for JACC-Imaging. His areas of research interest have included angiogenesis, attenuation-corrected SPECT imaging, patient risk stratification, and pharmacologic stress testing, and quality and appropriateness in cardiac imaging.
Education
University of Massachusetts, Medical School
Northwestern University
George Washington University, School of Medicine
Northwestern University
Articles
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy
2017
Although human mesenchymal stem cells (hMSCs) have been tested in ischemic cardiomyopathy, few studies exist in chronic nonischemic dilated cardiomyopathy (NIDCM).
Patient-Centered Imaging
2014
The current paper details the recommendations arising from an NIH-NHLBI/NCI-sponsored symposium held in November 2012, aiming to identify key components of a radiation accountability framework fostering patient-centered imaging and shared decision-making in cardiac imaging. Symposium participants, working in 3 tracks, identified key components of a framework to target critical radiation safety issues for the patient, the laboratory, and the larger population of patients with known or suspected cardiovascular disease.
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease
2014
A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons
Impact of Appropriate Use on the Prognostic Value of Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging
2013
Appropriate use criteria (AUC) have been developed to aid in the optimal use of single-photon emission computed tomography (SPECT)–myocardial perfusion imaging (MPI), a technique that is a mainstay of risk assessment for ischemic heart disease. The impact of appropriate use on the prognostic value of SPECT-MPI is unknown.
Appropriate Use of Cardiovascular Technology
2013
ACCF Appropriate Use Criteria Methodology Update: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force
Media Appearances
Medicine, diet and exercise may do more to heal your heart than stents or surgery says study
"What it really is a statement of, is that our medicines are really, really good nowadays," said Dr. Robert Hendel, Tulane Chief of Cardiology and Director of the Tulane University Heart and Vascular Institute.
Robert C. Hendel, MD: Tulane in Public Health
In an interview with MD Magazine®, Robert C. Hendel, MD, chair of Cardiovascular Medicine at Tulane, explained the critical public health education offered by the institution to its local New Orleans patients, as well as the global spread of their ‘appropriate use’ criteria education.
Doctors Told Not To Order Electrocardiograms For Low-Risk Patients
Other doctors welcomed the new recommendations, noting they are consistent with those of many other medical groups. "I think their recommendations are very reasonable," says Robert Hendel, chief of cardiology at Tulane University, speaking on behalf of the American College of Cardiology.
